ACH
WVE icon

ArrowMark Colorado Holdings’s Wave Life Sciences WVE Stock Holding History

ArrowMark Colorado Holdings’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-991,598
Closed -$7.95M – 327
2019
Q4 		$7.95M Buy
991,598
+3,555
+0.4% +$87.2K 0.07% 172
2019
Q3 		$20.3M Buy
988,043
+163,649
+20% +$3.75M 0.2% 102
2019
Q2 		$21.5M Buy
824,394
+334,329
+68% +$9.38M 0.21% 105
2019
Q1 		$19M Buy
490,065
+32,883
+7% +$1.33M 0.18% 115
2018
Q4 		$19.2M Buy
457,182
+13,722
+3% +$610K 0.2% 113
2018
Q3 		$22.2M Sell
443,460
-11,539
-3% -$521K 0.19% 114
2018
Q2 		$17.4M Buy
454,999
+66,280
+17% +$2.85M 0.16% 131
2018
Q1 		$15.6M Sell
388,719
-28,025
-7% -$1.18M 0.16% 135
2017
Q4 		$14.6M Sell
416,744
-33,776
-7% -$985K 0.15% 140
2017
Q3 		$9.8M Buy
450,520
+94,685
+27% +$1.9M 0.11% 167
2017
Q2 		$6.62M Buy
+355,835
New +$7.67M 0.08% 192

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ArrowMark Colorado Holdings's WVE Position: Q1 2020 in Review

ArrowMark Colorado Holdings sold out of Wave Life Sciences (WVE) in Q1 2020, closing a stake of 991,598 shares — an estimated $7.95M sold.

ArrowMark Colorado Holdings first reported a position in WVE in Q2 2017 and held it in 11 quarters. The position peaked at $22.2M in Q3 2018. 78 funds tracked by Wall St. Rank hold WVE as of Q1 2020.

  • ArrowMark Colorado Holdings reported no remaining Wave Life Sciences position as of Q1 2020 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 991,598 Wave Life Sciences shares in Q1 2020, an estimated $7.95M.
  • ArrowMark Colorado Holdings first reported a position in Wave Life Sciences in Q2 2017 and held it in 11 quarters.
  • ArrowMark Colorado Holdings's Wave Life Sciences position peaked at $22.2M in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2020.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2020, filed 15 May 2020.